| Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|
| Revenues | - | - | - | - | - | - | - | 4 | 9 | 27 | 28 |
|---|
| Cost of revenues | 627,362 | 2 | 3 | 14 | 23 | 9 | 3 | 2 | 3 | 7 | 9 |
|---|
| Depreciation and amortization | - | - | - | - | - | - | - | 1 | 1 | 842,000 | 417,000 |
|---|
| General and administrative expenses | - | - | - | - | - | - | - | - | - | 5 | 14 |
|---|
| Total costs and expenses | - | - | - | - | - | - | - | - | - | - | 24 |
|---|
| Income (loss) from operations | - | -1,434,975 | -3,738,216 | 1 | -4,782,653 | -3,843,679 | -11,719,151 | -17,858,000 | -11,597,000 | -85,000 | 4 |
|---|
| Interest expense | - | - | - | - | - | - | - | - | - | - | 4 |
|---|
| Impairment - goodwill | - | - | - | - | 670,000 | - | - | - | - | - | 10 |
|---|
| Impairment - intangibles | - | - | - | - | - | - | 31,861 | - | - | - | 1 |
|---|
| Impairment - property and equipment | - | - | - | - | - | - | - | - | - | - | 41,000 |
|---|
| Impairment - marketable securities | - | - | - | - | - | - | - | - | - | - | 4 |
|---|
| Loss on sale of note receivable | - | - | - | - | - | - | - | - | - | - | -47,000 |
|---|
| Realized gain (loss) - marketable securities | - | - | - | - | - | - | - | - | - | - | -8,799,000 |
|---|
| Unrealized gain (loss) - marketable securities | - | - | - | - | - | - | - | - | - | -7,904,000 | -3,792,000 |
|---|
| Change in fair value - contract assets | - | - | - | - | - | - | - | - | - | - | -1,504,000 |
|---|
| Realized gain (loss) - designated assets | - | - | - | - | - | - | - | - | - | - | -1,803,000 |
|---|
| Unrealized loss - designated assets | - | - | - | - | - | - | - | - | - | - | -762,000 |
|---|
| Change in fair value - preferred stock | - | - | - | - | - | - | - | - | - | - | 3 |
|---|
| Make-whole provision | - | - | - | - | - | - | - | - | - | - | 240,000 |
|---|
| Interest income | - | - | -673,347 | -3,775,945 | - | - | -2,030,321 | 9,000 | - | 42,000 | 12,000 |
|---|
| Other income (expense) | - | - | - | - | - | - | - | - | - | - | -1,495,000 |
|---|
| Total other income (expense) - net | - | - | - | - | 534,420 | - | 20 | 999,000 | -3,082,000 | -16,209,000 | -35,641,000 |
|---|
| Loss from continuing operations before provision for income tax benefit (expense) | -1,258,859 | -1,747,440 | -4,411,563 | -2,723,909 | -4,248,233 | -6,658,882 | 9 | -16,859,000 | -14,679,000 | -16,294,000 | -31,638,000 |
|---|
| Provision for income tax benefit (expense) | - | - | - | - | - | - | - | - | 26,000 | -127,000 | - |
|---|
| Loss from continuing operations | - | - | - | - | - | - | - | - | - | -16,167,000 | -31,638,000 |
|---|
| Loss on discontinued operations - net of tax benefits | - | - | - | - | - | - | - | - | - | -14,376,000 | - |
|---|
| Loss on disposal of subsidiary | - | - | - | - | - | - | - | - | - | 11 | - |
|---|
| Loss from discontinued operations | - | - | - | - | - | - | - | - | - | -25,060,000 | - |
|---|
| Net loss including non-controlling interest | - | - | - | - | - | - | - | - | - | -41,227,000 | -31,638,000 |
|---|
| Net loss attributable to SRAX, Inc. | -1,258,859 | -1,747,440 | -4,411,563 | -2,723,909 | -4,248,233 | -6,658,882 | 9 | -16,859,000 | -14,705,000 | -34,762,000 | -31,638,000 |
|---|
| Net loss per share - basic, Continuing operations | - | - | - | - | - | - | - | - | - | -0.69 | -1.21 |
|---|
| Net loss per share - diluted, Continuing operations | - | - | - | - | - | - | - | - | - | - | -1.21 |
|---|
| Net loss per share - basic, Discontinued operations | - | - | - | - | - | - | - | - | - | -0.79 | - |
|---|
| Net loss per share - basic | - | - | - | - | - | - | 0.86 | - | - | -1.48 | -1.21 |
|---|
| Net loss per share - diluted | - | - | - | - | - | - | 0.86 | - | - | -1.48 | -1.21 |
|---|